| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $11.5B | $11.2B | $11.5B | $10.8B | $9.6B | $3.5B | $0.6B | $0.7B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $1.9B | $2.3B | $2.5B | $1.7B | $1.5B | $-0.4B | $0.1B | $0.1B |
| Net Income | $-0.5B | $-0.3B | $0.8B | $-0.9B | $-1.0B | $-1.8B | $-0.0B | $-0.0B |
| EPS (Basic) | $-2.42 | $-1.29 | $3.65 | $-4.19 | $-4.83 | $-13.50 | $-0.17 | $0.00 |
| EPS (Diluted) | $-2.42 | $-1.29 | $3.64 | $-4.19 | $-4.83 | $-13.50 | $-0.17 | $0.00 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $31.6B | $32.6B | $33.4B | $33.5B | $38.0B | $36.4B | $5.6B | $5.9B |
| Current Assets | $1.8B | $1.7B | $2.0B | $2.1B | $6.0B | $6.7B | $0.6B | $0.6B |
| Cash & Equivalents | $0.9B | $0.9B | $1.0B | $1.0B | $1.1B | $1.8B | $0.2B | $0.2B |
| Total Liabilities | $28.0B | $28.2B | $28.6B | $29.8B | $33.5B | $31.4B | $4.5B | $4.9B |
| Current Liabilities | $2.3B | $2.3B | $2.7B | $2.7B | $5.3B | $2.6B | $0.7B | $0.4B |
| Stockholders' Equity | $3.5B | $4.2B | $4.6B | $3.7B | $4.5B | $5.0B | $1.1B | $1.0B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.3B | — | — | — | — | — | $0.3B | $0.3B |
| Investing Cash Flow | $-0.6B | — | — | — | — | — | $0.4B | $-1.3B |
| Capital Expenditures | $0.8B | $1.3B | $1.3B | $1.0B | $0.5B | $0.2B | $0.2B | $0.1B |
| Financing Cash Flow | $-0.8B | $-0.5B | — | — | — | $10.6B | $-0.7B | $1.0B |